
Feb 14 (Reuters) - Delcath Systems DCTH.O:
DELCATH SYSTEMS ANNOUNCES UPDATE TO NATIONAL COMPREHENSIVE CANCER NETWORK CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT OF METASTATIC UVEAL MELANOMA
DELCATH SYSTEMS: UPDATED NCCN GUIDELINES INCLUDE HEPZATO KIT AS CATEGORY 2A TREATMENT FOR PATIENTS WITH HEPATIC-DOMINANT UVEAL MELANOMA
Source text: ID:nBw4Rt5FZa
Further company coverage: DCTH.O